// App-Quantinova.ai

17 : Concomitant Use of Oral vs. Subcutaneous Methotrexate at Biologic Initiation: A Comparison of Biologic Treatment Survival in the Ontario Best Practice Research Initiative (OBRI) Cohort

Researchers

Presenter

  • Mohammad Movahedi

Principal Investigators

  • Angela Cesta

  • Xiuying Li

  • Sandra Couto

  • Emmanouil Rampakakis

  • John Sampalis

  • Claire Bombardier

Medical Centers

  • Toronto General Hospital, University of Toronto, Toronto, ON, Canada

  • UHN-OBRI, Toronto,Canada

  • Universtiy Health Network, Toronto, ON, Canada

  • Univ of Toronto, Toronto, Canada

Locations

  • Canada

Companies

  • JSS Medical Research

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Methotrexate

Outcome

  • Unknown

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved